Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

CannPal Animal Therapeutics Limited

INVESTOR PRESENTATION - CannPal Animal Therapeutics Limited

ASX:CP1

CannPal Animal Therapeutics Limited

Health

CannPal Animal Therapeutics Limited (CP1) is a pet pharmaceutical Company that has identified an opportunity to benefit from the rapidly growing medical cannabis sector, by developing standardised and dosage controlled, regulatory approved pharmaceuticals, derived from the cannabis plant. The Company is established to research, develop and commercialise regulatory approved, cannabinoid-derived therapeutics, for the global animal health markets, with an initial focus on cats and dogs, in the United States, Europe, Australia and other emerging global markets.

Read more

Market Cap

$16.76m

Price at Close

$0.18

4w avg. Volume

145.86k

4w avg. Turnover

$26.19k

Announcements
announcementt+2 movementdate
  • AC8: AusCann Leadership Post CannPal Acquisition

    Company Administration · Market sensitive

  • +2.78%

    07 Jan 2021

+2.78%

07 Jan 2021
  • Results of Annual General Meeting

    Notice Of Meeting

  • 0.00%

    20 Nov 2020

0.00%

20 Nov 2020
  • Chairman and CEO Address AGM 2020

    Periodic Reports

  • -3.57%

    19 Nov 2020

-3.57%

19 Nov 2020
  • AC8: AusCann and CannPal Enter into Scheme of Arrangement

    Takeover Announcements

  • +16.00%

    15 Nov 2020

+16.00%

15 Nov 2020
  • CannPal and AusCann Enter into Scheme of Arrangement

    Takeover Announcements · Market sensitive

  • +16.00%

    15 Nov 2020

+16.00%

15 Nov 2020
  • Trading Halt

    Stock Exchange Announcement · Market sensitive

  • 0.00%

    12 Nov 2020

0.00%

12 Nov 2020
  • Cash Flow Report and Market Update 30 Sep 2020

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    28 Oct 2020

0.00%

28 Oct 2020
  • Quarterly Cash Flow Report Market Update 30 Sep 2020

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    28 Oct 2020

0.00%

28 Oct 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • +4.35%

    18 Oct 2020

+4.35%

18 Oct 2020
  • CannPal Animal Health Investment USA Presentation

    Periodic Reports

  • -7.69%

    12 Oct 2020

-7.69%

12 Oct 2020
Market Data

Current Price

$0.18

52WK HIGH

$0.245

52WK LOW

$0.069

1YR RETURN

+9.09%

1YR RETURN VS. SECTOR

-28.42%

90 DAY RETURN

+56.52%

ASX RANK

1,613

/2,047

SECTOR RANK

146

/168

SHARES OUTSTANDING

93.13m
ASX:CP1

CannPal Animal Therapeutics Limited

Health

CannPal Animal Therapeutics Limited (CP1) is a pet pharmaceutical Company that has identified an opportunity to benefit from the rapidly growing medical cannabis sector, by developing standardised and dosage controlled, regulatory approved pharmaceuticals, derived from the cannabis plant. The Company is established to research, develop and commercialise regulatory approved, cannabinoid-derived therapeutics, for the global animal health markets, with an initial focus on cats and dogs, in the United States, Europe, Australia and other emerging global markets.

Read more

Market Cap

$16.76m

Price at Close

$0.18

4w avg. Volume

145.86k

4w avg. Turnover

$26.19k

ASX:CP1 is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.